Lista de obras - Francisca Mutapi - Dominio Público Uruguay

A Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model.

artículo científico publicado en 2015

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

artículo científico publicado en 1997

Acquired immune heterogeneity and its sources in human helminth infection.

artículo científico publicado en 2010

Advances in parasite control in Africa: from basic science to translation

artículo científico publicado en 2012

Africa should set its own health-research agenda

scientific article published on 01 November 2019

Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection

artículo científico publicado en 2012

Age‐Related and Infection Intensity–Related Shifts in Antibody Recognition of Defined Protein Antigens in a Schistosome‐Exposed Population

artículo científico publicado en 2008

Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium

artículo científico publicado en 2012

Atopy is inversely related to schistosome infection intensity: a comparative study in Zimbabwean villages with distinct levels of Schistosoma haematobium infection

artículo científico publicado en 2012

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

article

CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1.

artículo científico publicado en 2014

Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.

artículo científico publicado en 1998

Changing policy and practice in the control of pediatric schistosomiasis

artículo científico publicado en 2015

Chemotherapy Accelerates the Development of Acquired Immune Responses toSchistosoma haematobiumInfection ⬇️

artículo científico publicado el 1 de julio de 1998

Chemotherapy-induced, age-related changes in antischistosome antibody responses

artículo científico publicado en 2003

Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children

artículo científico publicado en 2012

Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells

artículo científico publicado en 2012

Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status

artículo científico publicado en 2010

Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children

artículo científico publicado en 2011

Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.

artículo científico publicado en 2005

Coinfections and comorbidities in African health systems: At the interface of infectious and noninfectious diseases

article

Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children

artículo científico publicado en 2016

Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes

artículo científico publicado en 2014

Consequences of polyparasitism on anaemia among primary school children in Zimbabwe.

artículo científico publicado en 2010

Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.

artículo científico publicado en 2003

Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age

artículo científico publicado en 2007

Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment

artículo científico publicado en 2014

Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children

artículo científico publicado en 2015

Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4

artículo científico publicado en 2011

Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans

article

Distribution of schistosomiasis and soil transmitted helminthiasis in Zimbabwe: towards a national plan of action for control and elimination

artículo científico publicado en 2014

Down Regulation of the TCR Complex CD3ζ-Chain on CD3+ T Cells: A Potential Mechanism for Helminth-Mediated Immune Modulation

artículo científico publicado en 2015

Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.

artículo científico publicado en 2008

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

artículo científico publicado en 2008

Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study

artículo científico publicado en 2011

Elevation of C-reactive protein, P-selectin and Resistin as potential inflammatory biomarkers of urogenital Schistosomiasis exposure in preschool children

artículo científico publicado en 2019

Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis.

artículo científico publicado en 2011

Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria

artículo científico publicado en 2011

Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe

artículo científico publicado en 2014

Getting a GRiPP on everyday schistosomiasis: experience from Zimbabwe

artículo científico publicado en 2016

Group 2 ILCs: A way of enhancing immune protection against human helminths?

artículo científico publicado en 2017

Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment

artículo científico publicado en 2015

Helminth parasite proteomics: from experimental models to human infections ⬇️

artículo científico publicado el 28 de marzo de 2012

High seroprevalence of enterovirus infections in apes and old world monkeys

artículo científico publicado en 2012

Human schistosome infection and allergic sensitisation

artículo científico publicado en 2012

Human schistosomiasis in the post mass drug administration era.

artículo científico publicado en 2016

Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children

artículo científico publicado en 2015

Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden

artículo científico publicado en 2006

Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection

artículo científico publicado en 2013

Improving diagnosis of urogenital schistosome infection

artículo científico publicado en 2011

In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.

artículo científico publicado en 2019

Infection and treatment immunizations for successful parasite vaccines

artículo científico publicado en 2013

Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis

artículo científico publicado en 2012

Knowledge attitudes and practices of grade three primary schoolchildren in relation to schistosomiasis, soil transmitted helminthiasis and malaria in Zimbabwe

artículo científico publicado en 2011

Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates

artículo científico publicado en 2015

On the calculation of intestinal schistosome infection intensity.

artículo científico publicado en 2003

Paediatric schistosomiasis: What we know and what we need to know.

artículo científico publicado en 2018

Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection

artículo científico publicado en 2014

Peptidases of Trichobilharzia regenti (Schistosomatidae) and its molluscan host Radix peregra S. Lat. (Lymnaeidae): construction and screening of cDNA library from intramolluscan stages of the parasite.

artículo científico publicado en 2007

Population level changes in schistosome-specific antibody levels following chemotherapy

artículo científico publicado en 2019

Positive impact of preventative chemotherapy during a national helminth control program: Perception and KAP

scientific article published on 24 August 2020

Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens

artículo científico publicado en 2005

Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium ⬇️

artículo científico publicado en 2014

Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium

artículo científico publicado en 2012

Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms

artículo científico publicado en 2012

Putting the treatment of paediatric schistosomiasis into context

artículo científico publicado en 2017

Regulatory and activated T cells in human Schistosoma haematobium infections

artículo científico publicado en 2011

SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe

scientific article published on 31 March 2021

Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children

scientific article published on 14 December 2020

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies

artículo científico publicado en 2012

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel

artículo científico publicado en 2011

Schistosome infection intensity is inversely related to auto-reactive antibody levels

artículo científico publicado en 2011

Schistosomiasis therapeutics: whats in the pipeline?

artículo científico publicado en 2015

Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni.

artículo científico publicado en 2011

Seroepidemiology of Plasmodium species infections in Zimbabwean population

artículo científico publicado en 2016

Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe

scientific article published on 22 June 2020

Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infection

scientific article published on 14 May 2013

Sources of heterogeneity in human monocyte subsets

artículo científico publicado en 2013

Stochastic simulation and the detection of immunity to schistosome infections.

artículo científico publicado en 2000

Strengthening national health research systems in the WHO African Region - progress towards universal health coverage

artículo científico publicado en 2019

The anthelmintic drug praziquantel promotes human Tr1 differentiation

scientific article published on 30 January 2019

The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe

artículo científico publicado en 2008

The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium

scientific article published in 2002

The gut microbiome in the helminth infected host

artículo científico publicado en 2015

The helminth parasite proteome at the host-parasite interface - Informing diagnosis and control

artículo científico

The microbiota and helminths: sharing the same niche in the human host

artículo científico publicado en 2014

The predicted impact of immunosuppression upon population age-intensity profiles for schistosomiasis

artículo científico publicado en 2008

Trichuris suisova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response

article

Universal Health Coverage in Africa: Coinfections and Comorbidities

article

What are SARS-CoV-2 genomes from the WHO Africa region member states telling us?

artículo científico publicado en 2021

p values for pathogens: statistical inference from infectious-disease data

artículo científico publicado en 2002

Lista de obras de Francisca Mutapi

A Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model.

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

Acquired immune heterogeneity and its sources in human helminth infection.

Advances in parasite control in Africa: from basic science to translation

Africa should set its own health-research agenda

Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection

Age‐Related and Infection Intensity–Related Shifts in Antibody Recognition of Defined Protein Antigens in a Schistosome‐Exposed Population

Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium

Atopy is inversely related to schistosome infection intensity: a comparative study in Zimbabwean villages with distinct levels of Schistosoma haematobium infection

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1.

Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.

Changing policy and practice in the control of pediatric schistosomiasis

Chemotherapy Accelerates the Development of Acquired Immune Responses toSchistosoma haematobiumInfection ⬇️

Chemotherapy-induced, age-related changes in antischistosome antibody responses

Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children

Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells

Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status

Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children

Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups.

Coinfections and comorbidities in African health systems: At the interface of infectious and noninfectious diseases

Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children

Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes

Consequences of polyparasitism on anaemia among primary school children in Zimbabwe.

Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.

Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age

Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment

Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children

Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4

Dissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humans

Distribution of schistosomiasis and soil transmitted helminthiasis in Zimbabwe: towards a national plan of action for control and elimination

Down Regulation of the TCR Complex CD3ζ-Chain on CD3+ T Cells: A Potential Mechanism for Helminth-Mediated Immune Modulation

Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study

Elevation of C-reactive protein, P-selectin and Resistin as potential inflammatory biomarkers of urogenital Schistosomiasis exposure in preschool children

Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis.

Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria

Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe

Getting a GRiPP on everyday schistosomiasis: experience from Zimbabwe

Group 2 ILCs: A way of enhancing immune protection against human helminths?

Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment

Helminth parasite proteomics: from experimental models to human infections ⬇️

High seroprevalence of enterovirus infections in apes and old world monkeys

Human schistosome infection and allergic sensitisation

Human schistosomiasis in the post mass drug administration era.

Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children

Immuno-epidemiology of human Schistosoma haematobium infection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden

Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection

Improving diagnosis of urogenital schistosome infection

In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.

Infection and treatment immunizations for successful parasite vaccines

Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis

Knowledge attitudes and practices of grade three primary schoolchildren in relation to schistosomiasis, soil transmitted helminthiasis and malaria in Zimbabwe

Of monkeys and men: immunomic profiling of sera from humans and non-human primates resistant to schistosomiasis reveals novel potential vaccine candidates

On the calculation of intestinal schistosome infection intensity.

Paediatric schistosomiasis: What we know and what we need to know.

Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection

Peptidases of Trichobilharzia regenti (Schistosomatidae) and its molluscan host Radix peregra S. Lat. (Lymnaeidae): construction and screening of cDNA library from intramolluscan stages of the parasite.

Population level changes in schistosome-specific antibody levels following chemotherapy

Positive impact of preventative chemotherapy during a national helminth control program: Perception and KAP

Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens

Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium ⬇️

Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium

Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms

Putting the treatment of paediatric schistosomiasis into context

Regulatory and activated T cells in human Schistosoma haematobium infections

SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe

Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel

Schistosome infection intensity is inversely related to auto-reactive antibody levels

Schistosomiasis therapeutics: whats in the pipeline?

Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni.

Seroepidemiology of Plasmodium species infections in Zimbabwean population

Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe

Soluble CD23 levels are inversely associated with atopy and parasite-specific IgE levels but not with polyclonal IgE levels in people exposed to helminth infection

Sources of heterogeneity in human monocyte subsets

Stochastic simulation and the detection of immunity to schistosome infections.